Get started
Author

Neil W. DeLapp

Observed names: N W DeLapp, N. DeLapp, N. Delapp, N.W. DeLapp, N.W. Delapp, Neil DeLapp, Neil Delapp, Neil W DeLapp, Neil W Delapp, Neil W. Delapp
OpenAlex ID: A5109908683
Therapeutic Opportunities for Muscarinic Receptors in the Central Nervous System
2000 · Christian C. Felder, Frank P. Bymaster, et al. · Journal of Medicinal Chemistry · 235
In vitro and in vivo biochemistry of olanzapine: a novel, atypical antipsychotic drug.
1997 · F P Bymaster, K Rasmussen, et al. · PubMed · 161
Potent antagonism of 5-HT3 and 5-HT6 receptors by olanzapine
2001 · Frank P Bymaster, Julie F Falcone, et al. · European Journal of Pharmacology · 123
The Minimum Significant Ratio: A Statistical Parameter to Characterize the Reproducibility of Potency Estimates from Concentration-Response Assays and Estimation by Replicate-Experiment Studies
2006 · Brian J. Eastwood, Mark W. Farmen, et al. · SLAS DISCOVERY · 122
PDF
Determination of [35S]Guanosine-5′-O-(3-thio)Triphosphate Binding Mediated by Cholinergic Muscarinic Receptors in Membranes from Chinese Hamster Ovary Cells and Rat Striatum Using an Anti-G Protein Scintillation Proximity Assay
1999 · Neil W. Delapp, Jamie H. McKinzie, et al. · Journal of Pharmacology and Experimental Therapeutics · 116
Lu AE58054, a 5-HT6 antagonist, reverses cognitive impairment induced by subchronic phencyclidine in a novel object recognition test in rats
2010 · Jorn Arnt, Benny Bang-Andersen, et al. · The International Journal of Neuropsychopharmacology · 107
PDF
Xanomeline: A selective muscarinic agonist for the treatment of Alzheimer's disease
1997 · Frank P. Bymaster, Celia A. Whitesitt, et al. · Drug Development Research · 105
M1 muscarinic receptor signaling in mouse hippocampus and cortex
2002 · Amy C Porter, Frank P Bymaster, et al. · Brain Research · 90
Muscarinic Receptor Agonists, Like Dopamine Receptor Antagonist Antipsychotics, Inhibit Conditioned Avoidance Response in Rats
1999 · Harlan E. Shannon, John C. Hart, et al. · Journal of Pharmacology and Experimental Therapeutics · 76
Unexpected antipsychotic-like activity with the muscarinic receptor ligand (5R,6R)6-(3-propylthio-1,2,5-thiadiazol-4-yl)-1-azabicyclo[3.2.1]octane
1998 · Frank P Bymaster, Harlan E Shannon, et al. · European Journal of Pharmacology · 65
Xanomeline compared to other muscarinic agents on stimulation of phosphoinositide hydrolysis in vivo and other cholinomimetic effects
1998 · Frank P. Bymaster, Petra A. Carter, et al. · Brain Research · 60
Potential role of muscarinic receptors in schizophrenia
1999 · Frank P. Bymaster, Harlan E. Shannon, et al. · Life Sciences · 54
The muscarinic M1 agonist xanomeline increases soluble amyloid precursor protein release from chinese hamster ovary-m1 cells
1995 · Kris Eckols, Frank P. Bymaster, et al. · Life Sciences · 53
Effect of Basic Fibroblast Growth Factor (bFGF) and Insulin-Like Growth Factors Type I (IGF-I) and Type II (IGF-II) on Adult Human Keratinocyte Growth and Fibronectin Secretion
1990 · Neil W. DeLapp, Donna K. Dieckman · Journal of Investigative Dermatology · 53
Intrathecal pertussis toxin produces hyperalgesia and allodynia in mice
1997 · Daniel E Womer, Neil W DeLapp, et al. · Pain · 52
An Allosteric Potentiator of the Dopamine D1 Receptor Increases Locomotor Activity in Human D1 Knock-In Mice without Causing Stereotypy or Tachyphylaxis
2016 · Kjell A. Svensson, Beverly A. Heinz, et al. · Journal of Pharmacology and Experimental Therapeutics · 45
PDF
The antibody-capture [35S]GTPγS scintillation proximity assay: a powerful emerging technique for analysis of GPCR pharmacology
2004 · Neil W. DeLapp · Trends in Pharmacological Sciences · 43
Muscarinic receptor agonists decrease cocaine self-administration rates in drug-naive mice
2000 · Thøger Rasmussen, Per Sauerberg, et al. · European Journal of Pharmacology · 40
The muscarinic receptor agonist BuTAC, a novel potential antipsychotic, does not impair learning and memory in mouse passive avoidance
2001 · Thøger Rasmussen, Anders Fink-Jensen, et al. · Schizophrenia Research · 37
Muscarinic Agonists with Antipsychotic-like Activity: Structure−Activity Relationships of 1,2,5-Thiadiazole Analogues with Functional Dopamine Antagonist Activity
1998 · Per Sauerberg, Lone Jeppesen, et al. · Journal of Medicinal Chemistry · 34
Butylthio[2.2.2] (NNC 11–1053/LY297802): An Orally Active Muscarinic Agonist Analgesic
1997 · Michael D.B. Swedberg, Malcolm J. Sheardown, et al. · Journal of Pharmacology and Experimental Therapeutics · 31
Effects of the M1 Agonist Xanomeline on Processing of Human β-Amyloid Precursor Protein (FAD, Swedish Mutant) Transfected into Chinese Hamster Ovary-m1 Cells
1998 · Neil DeLapp, Su Wu, et al. · Biochemical and Biophysical Research Communications · 29
Pharmacology of Butylthio[2.2.2] (LY297802/NNC11-1053): A Novel Analgesic with Mixed Muscarinic Receptor Agonist and Antagonist Activity
1997 · Harlan E. Shannon, Malcolm J. Sheardown, et al. · Journal of Pharmacology and Experimental Therapeutics · 26
Forskolin Stimulation of Cyclic AMP Accumulation in Rat Brain Cortex Slices Is Markedly Enhanced by Endogenous Adenosine
1992 · Neil W. DeLapp, Kris Eckols · Journal of Neurochemistry · 25
Muscarinic agonists exhibit functional dopamine antagonism in unilaterally 6-OHDA lesioned rats
1998 · Anders Fink-Jensen, Peter Kristensen, et al. · Neuroreport · 24
Works count: 66
Citation count: 1,962
H-index: 24
I10-index: 34
Year
Topic
Type